Hartl Janine, Scherer Marcus N, Loss Martin, Schnitzbauer Andreas, Farkas Stefan, Baier Lucia, Szecsey Alexander, Schoelmerich Juergen, Schlitt Hans-Juergen, Kirchner Gabriele I
Department of Internal Medicine I, University Hospital of Regensburg, Regensburg, Germany.
Scand J Gastroenterol. 2011 Oct;46(10):1257-66. doi: 10.3109/00365521.2011.603160. Epub 2011 Aug 5.
Alcohol-toxic liver cirrhosis (ALC) is one of the main indications for liver transplantation (LT). The aim of the study is to define predictors for alcohol recidivism and to identify the outcome and quality of life of such patients.
From March 2003 to July 2009, 226 patients underwent LT in our centre. In 53% liver cirrhosis was caused by alcohol abuse (sole/cofactor). Outcome and alcohol recidivism were assessed using patients' records, laboratory tests and interviews (patient, family members and family doctor). Furthermore, patients received an SF-36 quality of life and a self-designed questionnaire anonymously.
Mean follow-up after LT was 31 + 23 months. The 5-year survival rate after LT in patients with ALC was significantly better compared to patients with other indications (78 vs. 64%; p = 0.016). Quality of life of both patient groups was comparable. After LT, alcohol recidivism rate was 16%. Patients with an alcohol abstinence of <3 months before LT had a significantly higher (p = 0.012) rate of alcohol recidivism in comparison to those with an abstinence of >3 months. Another predictor for alcohol recidivism was the patients' non-acceptance of having an alcohol problem before LT (p = 0.001).
ALC is a good indication for LT. An alcohol abstinence of <3 months before LT and a non-acceptance of having an alcohol problem are strong predictors for alcohol recidivism after LT.
酒精性中毒性肝硬化(ALC)是肝移植(LT)的主要适应症之一。本研究的目的是确定酒精复饮的预测因素,并确定此类患者的预后和生活质量。
2003年3月至2009年7月,226例患者在我们中心接受了肝移植。53%的肝硬化是由酒精滥用(单独/协同因素)引起的。使用患者记录、实验室检查和访谈(患者、家庭成员和家庭医生)评估预后和酒精复饮情况。此外,患者还匿名接受了SF-36生活质量和自行设计的问卷调查。
肝移植后的平均随访时间为31±23个月。与其他适应症患者相比,ALC患者肝移植后的5年生存率显著更高(78%对64%;p = 0.016)。两组患者的生活质量相当。肝移植后,酒精复饮率为16%。肝移植前戒酒时间<3个月的患者与戒酒时间>3个月的患者相比,酒精复饮率显著更高(p = 0.012)。酒精复饮的另一个预测因素是患者在肝移植前不承认有酒精问题(p = 0.001)。
ALC是肝移植的良好适应症。肝移植前戒酒时间<3个月和不承认有酒精问题是肝移植后酒精复饮的有力预测因素。